These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35268690)
1. Cellular Effects of Cyclodextrins: Studies on HeLa Cells. Rusznyák Á; Palicskó M; Malanga M; Fenyvesi É; Szente L; Váradi J; Bácskay I; Vecsernyés M; Réti-Nagy KS; Vasvári G; Haimhoffer Á; Fenyvesi F Molecules; 2022 Feb; 27(5):. PubMed ID: 35268690 [TBL] [Abstract][Full Text] [Related]
2. Investigation of the Cellular Effects of Beta- Cyclodextrin Derivatives on Caco-2 Intestinal Epithelial Cells. Rusznyák Á; Malanga M; Fenyvesi É; Szente L; Váradi J; Bácskay I; Vecsernyés M; Vasvári G; Haimhoffer Á; Fehér P; Ujhelyi Z; Nagy B; Fejes Z; Fenyvesi F Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33504045 [TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin Complexation Improves the Solubility and Caco-2 Permeability of Chrysin. Fenyvesi F; Nguyen TLP; Haimhoffer Á; Rusznyák Á; Vasvári G; Bácskay I; Vecsernyés M; Ignat SR; Dinescu S; Costache M; Ciceu A; Hermenean A; Váradi J Materials (Basel); 2020 Aug; 13(16):. PubMed ID: 32824341 [TBL] [Abstract][Full Text] [Related]
4. Fluorescently labeled methyl-beta-cyclodextrin enters intestinal epithelial Caco-2 cells by fluid-phase endocytosis. Fenyvesi F; Réti-Nagy K; Bacsó Z; Gutay-Tóth Z; Malanga M; Fenyvesi É; Szente L; Váradi J; Ujhelyi Z; Fehér P; Szabó G; Vecsernyés M; Bácskay I PLoS One; 2014; 9(1):e84856. PubMed ID: 24416301 [TBL] [Abstract][Full Text] [Related]
5. Endocytosis of fluorescent cyclodextrins by intestinal Caco-2 cells and its role in paclitaxel drug delivery. Réti-Nagy K; Malanga M; Fenyvesi É; Szente L; Vámosi G; Váradi J; Bácskay I; Fehér P; Ujhelyi Z; Róka E; Vecsernyés M; Balogh G; Vasvári G; Fenyvesi F Int J Pharm; 2015 Dec; 496(2):509-17. PubMed ID: 26498369 [TBL] [Abstract][Full Text] [Related]
6. [Cytotoxic examinations of various cyclodextrin derivatives on Caco-2 cells]. Kiss T; Fenyvesi F; Kovácsné BI; Fehér P; Leposáné KR; Váradi J; Szente L; Fenyvesi E; Iványi R; Vecsernyés M Acta Pharm Hung; 2007; 77(2):150-4. PubMed ID: 17933275 [TBL] [Abstract][Full Text] [Related]
7. Complexation with Random Methyl-β-Cyclodextrin and (2-Hidroxypropyl)-β-Cyclodextrin Enhances In Vivo Anti-Fibrotic and Anti-Inflammatory Effects of Chrysin via the Inhibition of NF-κB and TGF-β1/Smad Signaling Pathways and Modulation of Hepatic Pro/Anti-Fibrotic miRNA. Ciceu A; Balta C; Herman H; Gharbia S; Ignat SR; Dinescu S; Váradi J; Fenyvesi F; Gyöngyösi S; Hermenean A; Costache M Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668543 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis. Gharbia S; Balta C; Herman H; Rosu M; Váradi J; Bácskay I; Vecsernyés M; Gyöngyösi S; Fenyvesi F; Voicu SN; Stan MS; Cristian RE; Dinischiotu A; Hermenean A Front Pharmacol; 2018; 9():883. PubMed ID: 30150935 [TBL] [Abstract][Full Text] [Related]
9. Erlotinib complexation with randomly methylated Erdoğar N; Akkın S; Varan G; Bilensoy E Pharm Dev Technol; 2021 Sep; 26(7):797-806. PubMed ID: 34219578 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins. Upadhye SB; Kulkarni SJ; Majumdar S; Avery MA; Gul W; ElSohly MA; Repka MA AAPS PharmSciTech; 2010 Jun; 11(2):509-17. PubMed ID: 20333489 [TBL] [Abstract][Full Text] [Related]
11. Effects of cyclodextrins on drug delivery through biological membranes. Loftsson T; Vogensen SB; Brewster ME; Konrádsdóttir F J Pharm Sci; 2007 Oct; 96(10):2532-46. PubMed ID: 17630644 [TBL] [Abstract][Full Text] [Related]
12. Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components. Maestrelli F; Cirri M; Mennini N; Zerrouk N; Mura P Eur J Pharm Biopharm; 2011 Aug; 78(3):385-93. PubMed ID: 21439375 [TBL] [Abstract][Full Text] [Related]
13. Complexation with Random Methyl-β-Cyclodextrin and (2-Hydroxypropyl)-β-Cyclodextrin Promotes Chrysin Effect and Potential for Liver Fibrosis Therapy. Ignat SR; Dinescu S; Váradi J; Fenyvesi F; Nguyen TLP; Ciceu A; Hermenean A; Costache M Materials (Basel); 2020 Nov; 13(21):. PubMed ID: 33171970 [TBL] [Abstract][Full Text] [Related]
14. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state. Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856 [TBL] [Abstract][Full Text] [Related]
15. Randomly methylated β-cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco-2 cell monolayer. Fenyvesi F; Kiss T; Fenyvesi E; Szente L; Veszelka S; Deli MA; Váradi J; Fehér P; Ujhelyi Z; Tósaki A; Vecsernyés M; Bácskay I J Pharm Sci; 2011 Nov; 100(11):4734-44. PubMed ID: 21660974 [TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state. Jablan J; Szalontai G; Jug M J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722 [TBL] [Abstract][Full Text] [Related]
17. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs. Wu WM; Wu J; Bodor N Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189 [TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease. Kondo Y; Tokumaru H; Ishitsuka Y; Matsumoto T; Taguchi M; Motoyama K; Higashi T; Arima H; Matsuo M; Higaki K; Ohno K; Irie T Mol Genet Metab; 2016 Jul; 118(3):214-219. PubMed ID: 27184436 [TBL] [Abstract][Full Text] [Related]
19. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances. Srivalli KM; Mishra B AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622 [TBL] [Abstract][Full Text] [Related]
20. Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line. Daruházi AE; Kiss T; Vecsernyés M; Szente L; Szőke E; Lemberkovics E J Pharm Biomed Anal; 2013 Oct; 84():112-6. PubMed ID: 23810850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]